Versant Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $310K | Buy |
3,589
+1,220
| +51% | +$102K | 0.03% | 469 |
|
|
2026
Q2 | $160K | Sell |
2,369
-1,215
| -34% | -$80.9K | 0.01% | 715 |
|
|
2026
Q1 | $225K | Buy |
3,584
+1,488
| +71% | +$104K | 0.02% | 547 |
|
|
2025
Q4 | $139K | Buy |
2,096
+1,665
| +386% | +$108K | 0.02% | 623 |
|
|
2025
Q3 | $29K | Sell |
431
-19
| -4% | -$1.5K | ﹤0.01% | 1359 |
|
|
2025
Q2 | $39.3K | Buy |
+450
| New | +$35.3K | 0.01% | 1112 |
|
|
2025
Q1 | – | Sell |
-321
| Closed | -$25K | – | 2554 |
|
|
2024
Q4 | $25K | Buy |
+321
| New | +$23.8K | 0.01% | 918 |
|
|
2024
Q3 | – | Sell |
-40
| Closed | -$4.54K | – | 2035 |
|
|
2024
Q2 | $4.54K | Hold |
40
| – | – | ﹤0.01% | 1254 |
|
|
2024
Q1 | $5.55K | Hold |
40
| – | – | ﹤0.01% | 988 |
|
|
2023
Q4 | $4.96K | Buy |
40
+16
| +67% | +$1.64K | ﹤0.01% | 965 |
|
|
2023
Q3 | $2.24K | Buy |
24
+4
| +20% | +$451 | ﹤0.01% | 1265 |
|
|
2023
Q2 | $2.57K | Hold |
20
| – | – | ﹤0.01% | 1284 |
|
|
2023
Q1 | $2.32K | Hold |
20
| – | – | ﹤0.01% | 1232 |
|
|
2022
Q4 | $2.26K | Hold |
20
| – | – | ﹤0.01% | 1110 |
|
|
2022
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 1064 |
|
|
2022
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 1239 |
|
|
2022
Q1 | $3K | Sell |
20
-12
| -38% | -$1.31K | ﹤0.01% | 1022 |
|
|
2021
Q4 | $4K | Hold |
32
| – | – | ﹤0.01% | 949 |
|
|
2021
Q3 | $4K | Hold |
32
| – | – | ﹤0.01% | 946 |
|
|
2021
Q2 | $3K | Buy |
32
+4
| +14% | +$384 | ﹤0.01% | 1031 |
|
|
2021
Q1 | $3K | Buy |
28
+8
| +40% | +$751 | ﹤0.01% | 1143 |
|
|
2020
Q4 | $1K | Hold |
20
| – | – | ﹤0.01% | 1205 |
|
|
2020
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 1053 |
|
|
2020
Q2 | $2K | Hold |
20
| – | – | ﹤0.01% | 1046 |
|
|
2020
Q1 | $1K | Sell |
20
-4
| -17% | -$249 | ﹤0.01% | 1127 |
|
|
2019
Q4 | $1K | Hold |
24
| – | – | ﹤0.01% | 1218 |
|
|
2019
Q3 | $0 | Sell |
24
-156
| -87% | -$6.06K | ﹤0.01% | 1413 |
|
|
2019
Q2 | $6K | Buy |
180
+12
| +7% | +$377 | ﹤0.01% | 896 |
|
|
2019
Q1 | $5K | Hold |
168
| – | – | ﹤0.01% | 1099 |
|
|
2018
Q4 | $5K | Hold |
168
| – | – | ﹤0.01% | 1015 |
|
|
2018
Q3 | $6K | Hold |
168
| – | – | ﹤0.01% | 1025 |
|
|
2018
Q2 | $3K | Hold |
168
| – | – | ﹤0.01% | 1205 |
|
|
2018
Q1 | $3K | Hold |
168
| – | – | ﹤0.01% | 1186 |
|
|
2017
Q4 | $2K | Hold |
168
| – | – | ﹤0.01% | 1322 |
|
|
2017
Q3 | $2K | Sell |
168
-36
| -18% | -$636 | ﹤0.01% | 1242 |
|
|
2017
Q2 | $3K | Buy |
204
+36
| +21% | +$665 | ﹤0.01% | 1157 |
|
|
2017
Q1 | $3K | Hold |
168
| – | – | ﹤0.01% | 1149 |
|
|
2016
Q4 | $2K | Hold |
168
| – | – | ﹤0.01% | 1181 |
|
|
2016
Q3 | $3K | Sell |
168
-20
| -11% | -$445 | ﹤0.01% | 1087 |
|
|
2016
Q2 | $3K | Hold |
188
| – | – | ﹤0.01% | 1067 |
|
|
2016
Q1 | $3K | Hold |
188
| – | – | ﹤0.01% | 1046 |
|
|
2015
Q4 | $3K | Buy |
+188
| New | +$3.91K | ﹤0.01% | 1040 |
|
Other funds holding DXCM
Versant Capital Management's DXCM Position: Q3 2026 in Review
Versant Capital Management increased its DexCom (DXCM) stake by 51% in Q3 2026, buying an estimated $102K and bringing the position to 3,589 shares worth $310K. The position accounts for 0.03% of the portfolio, ranked #469.
Versant Capital Management first reported a position in DXCM in Q4 2015 and has held it in 42 quarters since. 620 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- Versant Capital Management held 3,589 shares of DexCom worth $310K as of Q3 2026.
- Versant Capital Management bought 1,220 DexCom shares in Q3 2026, an estimated $102K.
- DexCom made up 0.03% of Versant Capital Management's portfolio in Q3 2026, its #469 holding.
- Versant Capital Management first reported a position in DexCom in Q4 2015 and has held it in 42 quarters since.
- 620 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.